US approves first new type of flu drug in 2 decades
TRENTON, N.J: U.S. health regulators have approved the first new type of flu drug in two decades.
Wednesday's approval of Xofluzafor people age 12 and older comes ahead of the brunt of this winter's flu season.
Xofluza (Zoh-FLEW'-Zeh) is a pill that can reduce flu symptoms after one just dose. It developed by the Roche Group and Japan's Shionogi.
It works about as well as Tamiflu, Roche's older flu treatment, which is also available in cheaper generic versions.
Health officials have said an estimated 80,000 Americans died of flu and its complications last winter, the disease's highest death toll in at least four decades.
Roche's Genentech unit plans to launch Xofluza within a few weeks. It will cost $150 without insurance.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd